Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 523

1.

Wide spectrum screening keratin as a marker of metaplastic spindle cell carcinoma of the breast: an immunohistochemical study of 24 patients.

Adem C, Reynolds C, Adlakha H, Roche PC, Nascimento AG.

Histopathology. 2002 Jun;40(6):556-62.

PMID:
12047767
2.

Metaplastic carcinomas of the breast. II. Spindle cell carcinoma.

Wargotz ES, Deos PH, Norris HJ.

Hum Pathol. 1989 Aug;20(8):732-40.

PMID:
2473024
3.

p63 is useful in the diagnosis of mammary metaplastic carcinomas.

Tse GM, Tan PH, Chaiwun B, Putti TC, Lui PC, Tsang AK, Wong FC, Lo AW.

Pathology. 2006 Feb;38(1):16-20.

PMID:
16484002
4.

Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms.

Attanoos RL, Dojcinov SD, Webb R, Gibbs AR.

Histopathology. 2000 Sep;37(3):224-31.

PMID:
10971698
5.

An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast.

Dunne B, Lee AH, Pinder SE, Bell JA, Ellis IO.

Hum Pathol. 2003 Oct;34(10):1009-15.

PMID:
14608534
6.

Low-grade (fibromatosis-like) spindle cell carcinoma of the breast.

Sneige N, Yaziji H, Mandavilli SR, Perez ER, Ordonez NG, Gown AM, Ayala A.

Am J Surg Pathol. 2001 Aug;25(8):1009-16.

PMID:
11474284
7.

Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas.

Gobbi H, Simpson JF, Jensen RA, Olson SJ, Page DL.

Mod Pathol. 2003 Sep;16(9):893-901.

8.
9.

Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions.

Chia Y, Thike AA, Cheok PY, Yong-Zheng Chong L, Man-Kit Tse G, Tan PH.

J Clin Pathol. 2012 Apr;65(4):339-47. doi: 10.1136/jclinpath-2011-200377. Epub 2012 Jan 18.

PMID:
22259180
10.

Metaplastic breast carcinoma: pathology and clinical outcome.

Bellino R, Arisio R, D'Addato F, Attini R, Durando A, Danese S, Bertone E, Grio R, Massobrio M.

Anticancer Res. 2003 Jan-Feb;23(1B):669-73.

PMID:
12680165
11.

Immunohistochemical distinction of cutaneous spindle cell carcinoma.

Morgan MB, Purohit C, Anglin TR.

Am J Dermatopathol. 2008 Jun;30(3):228-32. doi: 10.1097/DAD.0b013e31816de820.

PMID:
18496422
12.

Clinicopathological and immunohistochemical features of oral spindle cell carcinoma.

Romañach MJ, Azevedo RS, Carlos R, de Almeida OP, Pires FR.

J Oral Pathol Med. 2010 Apr;39(4):335-41. doi: 10.1111/j.1600-0714.2009.00843.x. Epub 2009 Dec 3.

PMID:
20002980
14.

Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases.

Carter MR, Hornick JL, Lester S, Fletcher CD.

Am J Surg Pathol. 2006 Mar;30(3):300-9.

PMID:
16538049
15.

Expression of cytokeratin by malignant meningiomas: diagnostic pitfall of cytokeratin to separate malignant meningiomas from metastatic carcinoma.

Liu Y, Sturgis CD, Bunker M, Saad RS, Tung M, Raab SS, Silverman JF.

Mod Pathol. 2004 Sep;17(9):1129-33.

16.

[Spindle cell carcinomas. Immunohistochemical analysis of 15 cases].

Avagnina A, Juárez MA, Elsner B.

Medicina (B Aires). 1990;50(4):325-9. Spanish.

PMID:
2130227
17.

Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.

Ozolek JA, Bastacky SI, Myers EN, Hunt JL.

Laryngoscope. 2005 Jun;115(6):1097-100.

PMID:
15933529
18.

β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.

Lacroix-Triki M, Geyer FC, Lambros MB, Savage K, Ellis IO, Lee AH, Reis-Filho JS.

Mod Pathol. 2010 Nov;23(11):1438-48. doi: 10.1038/modpathol.2010.141. Epub 2010 Aug 6.

19.
20.
Items per page

Supplemental Content

Write to the Help Desk